Here are all the posts from the How we think section that were published in July 2016. If you don’t see the post you’re looking for here, try our search feature or looking in the tags index.
These archives are only from the How we think section, if you’re looking for the archive for our company news page, click here.
| 19th July 2016
In the last 13 years, only one new drug has been approved for patients with Alzheimer's Disease. The most recently approved drug was in 2014, bringing the total number of agents approved across AD to 5. In this article, Consultant David Cooney explores the success rate of trials in AD and the reasons for this incredulous situation, as well as look at the some of the glimmers of light at the end of the tunnel.